(1)
ASSESSING THE CLINICAL FEATURES, DIAGNOSTIC APPROACHES, AND TREATMENT MODALITIES IN SUBJECTS WITH SECRETORY OTITIS MEDIA. Int. Res. J. Pharm. 2022, 13 (11), 17-23.